GGrantIndex
← Leaderboards

Anand Vaidya

Brigham And Women'S Hospital

$13,102,242
Attributed
$13,102,242
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,102,242 · 5

By mechanism

R01$12,198,982 · 3
K23$805,420 · 1
F32$97,840 · 1

Top collaborators

No co-investigators on record.

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Cardiovascular Diseases

Research focus

Cardiovascular DiseasesResearch DesignMediatingParticipantReninProspective StudiesPhysiologicalEpidemicPotassiumFutureAldosteronePublic Health RelevanceHypertensionMineralocorticoid ReceptorProtocols DocumentationDesignPhysiologyPharmaceutical PreparationsCardiovascular SystemRandomizedMedicalHigh RiskPreventRisk Factors

Grant awards (24)

Unrecognized Primary Aldosteronism as a Pathogenic Mechanism for Chronic Kidney Disease in Diabetes$751,623
R01 · FY2025 · DK · contact PI
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity$854,614
R01 · FY2024 · HL · contact PI
Unrecognized Primary Aldosteronism as a Pathogenic Mechanism for Chronic Kidney Disease in Diabetes$806,285
R01 · FY2024 · DK · contact PI
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity$872,054
R01 · FY2023 · HL · contact PI
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity$872,054
R01 · FY2022 · HL · contact PI
Subclinical Autonomous Aldosterone Secretion: Physiology, Pathogenesis, and Progression$739,332
R01 · FY2022 · DK · contact PI
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity$877,015
R01 · FY2021 · HL · contact PI
Subclinical Autonomous Aldosterone Secretion: Physiology, Pathogenesis, and Progression$740,587
R01 · FY2021 · DK · contact PI
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity$886,843
R01 · FY2020 · HL · contact PI
Subclinical Autonomous Aldosterone Secretion: Physiology, Pathogenesis, and Progression$740,587
R01 · FY2020 · DK · contact PI
Subclinical Autonomous Aldosterone Secretion: Physiology, Pathogenesis, and Progression$744,579
R01 · FY2019 · DK · contact PI
Interactions Between Adrenal and Parathyroid Hormones in Human Health$510,575
R01 · FY2019 · DK · contact PI
Subclinical Autonomous Aldosterone Secretion: Physiology, Pathogenesis, and Progression$771,943
R01 · FY2018 · DK · contact PI
Interactions Between Adrenal and Parathyroid Hormones in Human Health$510,575
R01 · FY2018 · DK · contact PI
Interactions Between Adrenal and Parathyroid Hormones in Human Health$510,575
R01 · FY2017 · DK · contact PI
Interactions Between Adrenal and Parathyroid Hormones in Human Health$489,330
R01 · FY2016 · DK · contact PI
Vitamin D and Hormonal Mechanisms of Cardiovascular Disease in Obesity$161,084
K23 · FY2016 · HL · contact PI
Interactions Between Adrenal and Parathyroid Hormones in Human Health$520,411
R01 · FY2015 · DK · contact PI
Vitamin D and Hormonal Mechanisms of Cardiovascular Disease in Obesity$161,084
K23 · FY2015 · HL · contact PI
Vitamin D and Hormonal Mechanisms of Cardiovascular Disease in Obesity$161,084
K23 · FY2014 · HL · contact PI
Vitamin D and Hormonal Mechanisms of Cardiovascular Disease in Obesity$161,084
K23 · FY2013 · HL · contact PI
Vitamin D and Hormonal Mechanisms of Cardiovascular Disease in Obesity$161,084
K23 · FY2012 · HL · contact PI
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity$42,050
F32 · FY2011 · HL · contact PI
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity$55,790
F32 · FY2010 · HL · contact PI